JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB264985

Human CDK17 (PCTAIRE2) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

CDK17 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 2 bp insertion in exon 2.

View Alternative Names

6430598J10Rik, CDK17_HUMAN, Cell division protein kinase 17, Cyclin-dependent kinase 17, EC 2.7.1.37, MGC25109, PCTAIRE-motif protein kinase 2, PCTK2, Protein kinase cdc2-related PCTAIRE-2, Serine/threonine-protein kinase PCTAIRE-2

2 Images
Sanger Sequencing - Human CDK17 (PCTAIRE2) knockout HeLa cell line (AB264985)
  • Sanger seq

Unknown

Sanger Sequencing - Human CDK17 (PCTAIRE2) knockout HeLa cell line (AB264985)

Allele-1 : 1 bp insertion in exon 2.

Sanger Sequencing - Human CDK17 (PCTAIRE2) knockout HeLa cell line (AB264985)
  • Sanger seq

Unknown

Sanger Sequencing - Human CDK17 (PCTAIRE2) knockout HeLa cell line (AB264985)

Allele-2 : 2 bp insertion in exon 2.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 2 bp insertion in exon 2

Antibiotic resistance

Puromycin 1µg/mL

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255448). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab264985-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab264985 Human CDK17 (PCTAIRE2) knockout HeLa cell line", "number":"AB264985-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
CDK17
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PCTAIRE2 also known as cyclin-dependent kinase 17 (CDK17) belongs to the large kinase family specifically involved in cell cycle regulation. It has a molecular mass of approximately 57 kDa and is mainly expressed in the brain and testis tissues. Like other members of the CDK family PCTAIRE2's activity is regulated by the binding of cyclins but it displays distinct substrate specificities. This protein structure includes a conserved kinase domain that suggests its role in phosphorylation and signal transduction processes.
Biological function summary

PCTAIRE2 functions in the modulation of neurodevelopmental processes and perhaps in the regulation of signal transmission in neurons. It may form complexes with various regulatory subunits affecting neuronal differentiation and outgrowth specifically in the brain. The presence of PCTAIRE2 in testis tissue indicates its potential role in reproductive biology though this function remains less understood compared to its neurological activities.

Pathways

PCTAIRE2 participates actively in pathways linked to neuronal signaling and development. The phosphorylation activity of PCTAIRE2 intertwines with proteins such as cyclins enabling the progression and regulation of cellular cycles particularly within neuronal cells. Moreover PCTAIRE2 links to pathways that include synaptic signaling interacting with related kinases that impact neuron structure and function though specific relationships to direct pathway members remain under ongoing investigation.

Researchers associate PCTAIRE2 with neurodegenerative conditions like Alzheimer's disease given its significant role in the brain. Its dysregulation could affect neuronal signaling pathways potentially leading to cognitive deficits. Additionally abnormalities in PCTAIRE2 expression relate to disorders of the male reproductive system though the precise mechanisms require further elucidation. Its interaction with key proteins such as tau protein may uncover further insights about its role in disease pathology where tauopathy plays a part.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com